de State Street Emergent Biosolutions EBS Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 24.6 M | Comprar |
2,929,238
+79,537
| +3% | +USD 665 k | ﹤0.01% | 2269 |
|
|
2026
Q1 | USD 23.7 M | Comprar |
2,849,701
+153,326
| +6% | +USD 1.59 M | ﹤0.01% | 2159 |
|
|
2025
Q4 | USD 33.3 M | Comprar |
2,696,375
+250,616
| +10% | +USD 2.69 M | ﹤0.01% | 1977 |
|
|
2025
Q3 | USD 21.6 M | Comprar |
2,445,759
+705,004
| +40% | +USD 5.48 M | ﹤0.01% | 2201 |
|
|
2025
Q2 | USD 11.1 M | Comprar |
1,740,755
+30,006
| +2% | +USD 172 k | ﹤0.01% | 2535 |
|
|
2025
Q1 | USD 8.31 M | Vender |
1,710,749
-253,015
| -13% | -USD 2.09 M | ﹤0.01% | 2646 |
|
|
2024
Q4 | USD 18.8 M | Comprar |
1,963,764
+52,437
| +3% | +USD 481 k | ﹤0.01% | 2267 |
|
|
2024
Q3 | USD 16 M | Comprar |
1,911,327
+1,713,200
| +865% | +USD 15.6 M | ﹤0.01% | 2344 |
|
|
2024
Q2 | USD 1.35 M | Vender |
198,127
-859,466
| -81% | -USD 3.7 M | ﹤0.01% | 3424 |
|
|
2024
Q1 | USD 2.68 M | Vender |
1,057,593
-5,358
| -0.5% | -USD 12.1 k | ﹤0.01% | 3185 |
|
|
2023
Q4 | USD 2.55 M | Vender |
1,062,951
-69,004
| -6% | -USD 162 k | ﹤0.01% | 3235 |
|
|
2023
Q3 | USD 3.85 M | Vender |
1,131,955
-5,662,189
| -83% | -USD 31.4 M | ﹤0.01% | 3047 |
|
|
2023
Q2 | USD 49.9 M | Comprar |
6,794,144
+1,388,594
| +26% | +USD 12.9 M | ﹤0.01% | 1681 |
|
|
2023
Q1 | USD 56 M | Vender |
5,405,550
-412,405
| -7% | -USD 4.99 M | ﹤0.01% | 1580 |
|
|
2022
Q4 | USD 68.7 M | Comprar |
5,817,955
+1,501,645
| +35% | +USD 23.2 M | ﹤0.01% | 1420 |
|
|
2022
Q3 | USD 90.6 M | Comprar |
4,316,310
+165,678
| +4% | +USD 4.61 M | 0.01% | 1168 |
|
|
2022
Q2 | USD 129 M | Comprar |
4,150,632
+681,162
| +20% | +USD 23.3 M | 0.01% | 1000 |
|
|
2022
Q1 | USD 142 M | Comprar |
3,469,470
+436,743
| +14% | +USD 19.3 M | 0.01% | 1065 |
|
|
2021
Q4 | USD 132 M | Comprar |
3,032,727
+628,137
| +26% | +USD 28.4 M | 0.01% | 1097 |
|
|
2021
Q3 | USD 120 M | Comprar |
2,404,590
+273,127
| +13% | +USD 16.5 M | 0.01% | 1125 |
|
|
2021
Q2 | USD 134 M | Comprar |
2,131,463
+217,984
| +11% | +USD 14 M | 0.01% | 1077 |
|
|
2021
Q1 | USD 178 M | Vender |
1,913,479
-232,112
| -11% | -USD 23.8 M | 0.01% | 843 |
|
|
2020
Q4 | USD 192 M | Comprar |
2,145,591
+283,423
| +15% | +USD 26 M | 0.01% | 766 |
|
|
2020
Q3 | USD 192 M | Vender |
1,862,168
-360,542
| -16% | -USD 38.9 M | 0.01% | 696 |
|
|
2020
Q2 | USD 176 M | Comprar |
2,222,710
+47,929
| +2% | +USD 3.57 M | 0.01% | 706 |
|
|
2020
Q1 | USD 126 M | Comprar |
2,174,781
+110,892
| +5% | +USD 6.39 M | 0.01% | 749 |
|
|
2019
Q4 | USD 111 M | Comprar |
2,063,889
+215,503
| +12% | +USD 11.7 M | 0.01% | 982 |
|
|
2019
Q3 | USD 96.6 M | Vender |
1,848,386
-715,579
| -28% | -USD 33.3 M | 0.01% | 1019 |
|
|
2019
Q2 | USD 124 M | Comprar |
2,563,965
+330,584
| +15% | +USD 15.8 M | 0.01% | 898 |
|
|
2019
Q1 | USD 113 M | Comprar |
2,233,381
+266,720
| +14% | +USD 15.7 M | 0.01% | 938 |
|
|
2018
Q4 | USD 117 M | Comprar |
1,966,661
+73,355
| +4% | +USD 4.73 M | 0.01% | 823 |
|
|
2018
Q3 | USD 125 M | Vender |
1,893,306
-76,497
| -4% | -USD 4.46 M | 0.01% | 935 |
|
|
2018
Q2 | USD 99.5 M | Comprar |
1,969,803
+239,684
| +14% | +USD 12.5 M | 0.01% | 1040 |
|
|
2018
Q1 | USD 91.1 M | Comprar |
1,730,119
+233,328
| +16% | +USD 11.6 M | 0.01% | 1068 |
|
|
2017
Q4 | USD 69.6 M | Comprar |
1,496,791
+82,220
| +6% | +USD 3.46 M | 0.01% | 1230 |
|
|
2017
Q3 | USD 57.2 M | Comprar |
1,414,571
+38,984
| +3% | +USD 1.41 M | ﹤0.01% | 1289 |
|
|
2017
Q2 | USD 46.6 M | Vender |
1,375,587
-76,885
| -5% | -USD 2.37 M | ﹤0.01% | 1395 |
|
|
2017
Q1 | USD 42.2 M | Comprar |
1,452,472
+213,500
| +17% | +USD 6.5 M | ﹤0.01% | 1426 |
|
|
2016
Q4 | USD 40.7 M | Vender |
1,238,972
-310,366
| -20% | -USD 9.3 M | ﹤0.01% | 1392 |
|
|
2016
Q3 | USD 48.9 M | Comprar |
1,549,338
+473,462
| +44% | +USD 13.8 M | ﹤0.01% | 1226 |
|
|
2016
Q2 | USD 30.2 M | Vender |
1,075,876
-23,726
| -2% | -USD 930 k | ﹤0.01% | 1457 |
|
|
2016
Q1 | USD 40 M | Comprar |
1,099,602
+208,084
| +23% | +USD 7.35 M | ﹤0.01% | 1266 |
|
|
2015
Q4 | USD 35.7 M | Vender |
891,518
-457,237
| -34% | -USD 15.9 M | ﹤0.01% | 1350 |
|
|
2015
Q3 | USD 38.4 M | Vender |
1,348,755
-86,079
| -6% | -USD 2.84 M | ﹤0.01% | 1317 |
|
|
2015
Q2 | USD 47.3 M | Comprar |
1,434,834
+63,703
| +5% | +USD 1.97 M | 0.01% | 1304 |
|
|
2015
Q1 | USD 39.4 M | Comprar |
1,371,131
+278,885
| +26% | +USD 8 M | ﹤0.01% | 1379 |
|
|
2014
Q4 | USD 29.7 M | Vender |
1,092,246
-60,411
| -5% | -USD 1.44 M | ﹤0.01% | 1512 |
|
|
2014
Q3 | USD 24.6 M | Vender |
1,152,657
-66,414
| -5% | -USD 1.52 M | ﹤0.01% | 1590 |
|
|
2014
Q2 | USD 27.4 M | Vender |
1,219,071
-36,497
| -3% | -USD 850 k | ﹤0.01% | 1597 |
|
|
2014
Q1 | USD 31.7 M | Comprar |
1,255,568
+423,849
| +51% | +USD 10.7 M | ﹤0.01% | 1466 |
|
|
2013
Q4 | USD 19.1 M | Vender |
831,719
-50,505
| -6% | -USD 1.05 M | ﹤0.01% | 1781 |
|
|
2013
Q3 | USD 16.8 M | Vender |
882,224
-88,178
| -9% | -USD 1.57 M | ﹤0.01% | 1808 |
|
|
2013
Q2 | USD 14 M | Comprar |
+970,402
| Nuevas | +USD 14.1 M | ﹤0.01% | 1855 |
|
Otros fondos que tienen EBS en su cartera
Posición de State Street en EBS: resumen de T2 2026
State Street aumentó su participación en Emergent Biosolutions (EBS) en 2.8% durante T2 2026, al comprar aproximadamente USD 665 k y elevar la posición a 2,929,238 acciones con un valor de USD 24.6 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2269.
State Street reportó por primera vez una posición en EBS en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 192 M en T3 2020. Al cierre de T2 2026, 194 fondos que sigue Wall St. Rank mantienen una posición en EBS.
- Al cierre de T2 2026, State Street tenía 2,929,238 acciones de Emergent Biosolutions con un valor de USD 24.6 M.
- State Street compró 79,537 acciones de Emergent Biosolutions en T2 2026, por un monto estimado de USD 665 k.
- Emergent Biosolutions representó ﹤0.01% de la cartera de State Street en T2 2026 y fue su posición número 2269.
- State Street reportó por primera vez una posición en Emergent Biosolutions en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de State Street en Emergent Biosolutions alcanzó su máximo de USD 192 M en T3 2020.
- Al cierre de T2 2026, 194 fondos que sigue Wall St. Rank tenían Emergent Biosolutions en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.